Genzyme Offers US$600 M for Bone Care
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 60 (Table of Contents)
Published: 5 Jun-2005
DOI: 10.3833/pdr.v2005.i60.673 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Genzyme launched a US$600 M cash bid for the increasingly profitable speciality pharmaceutical company Bone care International...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018